Developmental pharmacokinetics in pediatric populations

Area of Science:

• Pharmacology
• Pediatrics
• Drug Metabolism

Background:

• Knowledge of drug absorption and disposition in children has grown, but age-specific effects on pharmacokinetics, pharmacodynamics, and dosing remain unclear.
• Pediatric physiological differences, including gastric pH, emptying time, plasma protein levels, and body water composition, significantly impact drug absorption and distribution.

Purpose of the Study:

• To review age-related changes in drug absorption, distribution, metabolism, and elimination (ADME) in infants and children.
• To discuss age-related dosing regimens for the pediatric population based on pharmacokinetic and pharmacodynamic understanding.

Main Methods:

• Review of existing literature on pediatric pharmacokinetics and pharmacodynamics.
• Analysis of age-specific physiological factors influencing drug disposition in neonates, infants, and children.

Main Results:

• Immature metabolic processes and reduced renal excretion in neonates lead to decreased drug clearance and prolonged half-lives.
• Significant variations in drug absorption, distribution, metabolism, and elimination exist across different pediatric age groups.
• Limited data on pediatric pharmacodynamics necessitates a mechanistic approach to dose determination.

Conclusions:

• Age-related physiological maturation influences drug pharmacokinetics and pharmacodynamics in children.
• Continual modification of drug dosage regimens is required as pediatric patients mature.
• Understanding these age-related changes is essential for establishing appropriate and safe pediatric drug dosing.